In 2017, Zeng et al. demonstrated, for the first time, that miR-145 inhibits the stem-like properties of GC targeting directly CD44 observing, at the same time, that the overexpression of miR-145 in GC was correlated with chemoresistance [80]. This evidence concerns the gene CD44 and gastric cancer.